ArticleStatistics in medicine2025
Penalized Reduced Rank Regression for Multi-Outcome Survival Data Supports a Common Metabolic Risk Score for Age-Related Diseases.
Article in Statistics in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Penalized Reduced Rank Regression for Multi-Outcome Survival Data Supports a Common Metabolic Risk Score for Age-Related Diseases.Statistics in medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The increasing availability of multi-outcome data in health research presents new opportunities for understanding complex health processes, such as aging. Aging is a multifaceted process, encompassing both lifespan and health span, as well as the onset of age-related diseases. To model this complexity, we propose the penalized reduced rank regression model for multi-outcome survival data (penalized survRRR), which identifies shared latent factors driving multiple outcomes. The model imposes a rank constraint on the coefficient matrix to capture underlying mechanisms of aging while accommodating high-dimensional and correlated predictors and outcomes by introducing penalization. We discuss the statistical properties of this doubly regularized approach and show how the optimal number of ranks can be estimated from the data. We apply a lasso-penalized reduced rank regression model to 78,553 participants of the UK Biobank, using over 200 metabolic variables as predictors and the onset of seven age-related diseases and mortality as the outcomes of interest. Our results indicate that a rank 1 model provides the best fit to the data, resulting in a single metabolite-based score of age-related disease susceptibility. This highlights the potential of the penalized survRRR model to provide new insights into the nature of the relationship between metabolomics and age-related diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.